France · Startup
France · Cytheris, Inc.
Cytheris is focused on research and development of therapies for immune modulation.
Funding reportedLast round: Series D
What company datasets say Cytheris, Inc. raised
Funding, as reported
Reported in all48Min the source's currency
Rounds3
Last roundSeries D
Last round size15M
Last round dateJun 2010
Investors listed9
Is this your company?
Add your raise, your deck and your story, and put Cytheris, Inc. in front of investors. Or tell us what we have wrong.